Jean Jacques Bienaime - 10 May 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 10 May 2021
Net transactions value: -$432,460
Form type: 4
Filing time: 12 May 2021, 19:21:54 UTC
Previous filing: 10 May 2021
Next filing: 28 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Options Exercise	$225,509	+8,513	+2.8%	$26.49	312,352	10 May 2021	Direct	F1
transaction	BMRN	Common Stock	Sale	$657,970	-8,513	-2.7%	$77.29	303,839	10 May 2021	Direct	F1
holding	BMRN	Common Stock						247,533	10 May 2021	Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Options Exercise	$0	-8,513	-100%	$0.000000^*	0	10 May 2021	Common Stock	8,513	$26.49	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.
F2	Reflects the number of options outstanding after the transactions from this specific stock option grant.